메뉴 건너뛰기




Volumn 31, Issue 7, 2009, Pages 521-533

Matrix metalloproteinases: Discrete elevations in essential hypertension and hypertensive end-stage renal disease

Author keywords

End stage renal disease (ESRD); Essential hypertension; Inflammation; Matrix metalloproteinase (MMP)

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; STROMELYSIN; STROMELYSIN 2;

EID: 70449378212     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641960802668730     Document Type: Article
Times cited : (78)

References (21)
  • 1
    • 33646530080 scopus 로고    scopus 로고
    • Is hypertension an inflammatory process?
    • Boos CJ, Lip GY. Is hypertension an inflammatory process? Curr Pharm Des 2006;12: 1623-1635.
    • (2006) Curr Pharm des , vol.12 , pp. 1623-1635
    • Boos, C.J.1    Lip, G.Y.2
  • 3
    • 37349082926 scopus 로고    scopus 로고
    • Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
    • Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008;75: 346-359.
    • (2008) Biochem Pharmacol , vol.75 , pp. 346-359
    • Raffetto, J.D.1    Khalil, R.A.2
  • 4
    • 34250312341 scopus 로고    scopus 로고
    • The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases
    • Cauwe B, Van den Steen PE, Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 2007;42: 113-185.
    • (2007) Crit Rev Biochem Mol Biol , vol.42 , pp. 113-185
    • Cauwe, B.1    Van Den Steen, P.E.2    Opdenakker, G.3
  • 5
    • 49849083714 scopus 로고    scopus 로고
    • Proteinase activity and receptor cleavage: Mechanism for insulin resistance in spontaneously hypertensive rats
    • DeLano FA, Schmid-Schonbein GW. Proteinase activity and receptor cleavage: Mechanism for insulin resistance in spontaneously hypertensive rats. Hypertension 2008;52: 415-423.
    • (2008) Hypertension , vol.52 , pp. 415-423
    • Delano, F.A.1    Schmid-Schonbein, G.W.2
  • 6
    • 35148820132 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension
    • Zhou S, Feely J, Spiers JP, Mahmud A. Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension. J Hum Hypertens 2007;21: 861-867.
    • (2007) J Hum Hypertens , vol.21 , pp. 861-867
    • Zhou, S.1    Feely, J.2    Spiers, J.P.3    Mahmud, A.4
  • 7
    • 0033780333 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy
    • Li-Saw-Hee FL, Edmunds E, Blann AD, Beevers DG, Lip GY. Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy. Int J Cardiol 2000;75: 43-47.
    • (2000) Int J Cardiol , vol.75 , pp. 43-47
    • Li-Saw-Hee, F.L.1    Edmunds, E.2    Blann, A.D.3    Beevers, D.G.4    Lip, G.Y.5
  • 11
    • 36249017215 scopus 로고    scopus 로고
    • Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension
    • Tan J, Hua Q, Xing X, Wen J, Liu R, Yang Z. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension. Hypertens Res 2007;30: 959-963.
    • (2007) Hypertens Res , vol.30 , pp. 959-963
    • Tan, J.1    Hua, Q.2    Xing, X.3    Wen, J.4    Liu, R.5    Yang, Z.6
  • 13
    • 33646439273 scopus 로고    scopus 로고
    • Matrix metalloproteinases/tissue inhibitors of metalloproteinases: Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease
    • Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, McClure CD, Spinale FG, Zile MR. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006;113: 2089-2096.
    • (2006) Circulation , vol.113 , pp. 2089-2096
    • Ahmed, S.H.1    Clark, L.L.2    Pennington, W.R.3    Webb, C.S.4    Bonnema, D.D.5    Leonardi, A.H.6    McClure, C.D.7    Spinale, F.G.8    Zile, M.R.9
  • 14
    • 0032508355 scopus 로고    scopus 로고
    • Abnormalities of the extracellular degradation of collagen type i in essential hypertension
    • Laviades C, Varo N, Fernandez J, Mayor G, Gil MJ, Monreal I, Diez J. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 1998;98: 535-540.
    • (1998) Circulation , vol.98 , pp. 535-540
    • Laviades, C.1    Varo, N.2    Fernandez, J.3    Mayor, G.4    Gil, M.J.5    Monreal, I.6    Diez, J.7
  • 15
    • 36448992977 scopus 로고    scopus 로고
    • ACE inhibitors to block MMP-9 activity: New functions for old inhibitors
    • Jin Y, Han HC, Lindsey ML. ACE inhibitors to block MMP-9 activity: New functions for old inhibitors. J Mol Cell Cardiol 2007;43: 664-666.
    • (2007) J Mol Cell Cardiol , vol.43 , pp. 664-666
    • Jin, Y.1    Han, H.C.2    Lindsey, M.L.3
  • 16
    • 0037291886 scopus 로고    scopus 로고
    • Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment
    • Zervoudaki A, Economou E, Stefanadis C, Pitsavos C, Tsioufis K, Aggeli C, Vasiliadou K, Toutouza M, Toutouzas P. Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment. J Hum Hypertens 2003;17: 119-124.
    • (2003) J Hum Hypertens , vol.17 , pp. 119-124
    • Zervoudaki, A.1    Economou, E.2    Stefanadis, C.3    Pitsavos, C.4    Tsioufis, K.5    Aggeli, C.6    Vasiliadou, K.7    Toutouza, M.8    Toutouzas, P.9
  • 17
    • 0034805565 scopus 로고    scopus 로고
    • Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells
    • Jiang MC, Liao CF, Lee PH. Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells. Biochem Biophys Res Commun 2001;282: 671-677.
    • (2001) Biochem Biophys Res Commun , vol.282 , pp. 671-677
    • Jiang, M.C.1    Liao, C.F.2    Lee, P.H.3
  • 18
    • 33144474495 scopus 로고    scopus 로고
    • Role of angiotensin II receptor blockers in atherosclerotic plaque stability
    • Cipollone F, Fazia ML, Mezzetti A. Role of angiotensin II receptor blockers in atherosclerotic plaque stability. Expert Opin Pharmacother 2006;7: 277-285.
    • (2006) Expert Opin Pharmacother , vol.7 , pp. 277-285
    • Cipollone, F.1    Fazia, M.L.2    Mezzetti, A.3
  • 21
    • 33845419991 scopus 로고    scopus 로고
    • Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients
    • Pawlak K, Pawlak D, Mysliwiec M. Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients. Atherosclerosis 2007;190: 199-204.
    • (2007) Atherosclerosis , vol.190 , pp. 199-204
    • Pawlak, K.1    Pawlak, D.2    Mysliwiec, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.